Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Jennifer Munkley.

Newcastle AuthorsTitleYearFull text
Rebecca Garnham
Dr Daniel Geh
Ryan Nelson
Erik Ramon Gil
Laura Wilson
et al.
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer2024
Chile Siachisumo
Dr Sara Luzzi
Saad Aldalaqan
Dr Gerald Hysenaj
Caroline Dalgliesh
et al.
An anciently diverged family of RNA binding proteins maintain correct splicing of ultra-long exons through cryptic splice site repression2023
Rahul Advani
Dr Sara Luzzi
Dr Emma Scott
Caroline Dalgliesh
Dr Jennifer Munkley
et al.
Epithelial specific splicing regulator proteins as emerging oncogenes in aggressive prostate cancer2023
Rebecca Garnham
Dr Daniel Geh
Ryan Nelson
Erik Ramon Gil
Laura Wilson
et al.
ST3Gal1 synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer2023
Dr Emma Scott
Emily Archer Goode
Rebecca Garnham
Dr Kirsty Hodgson
Maggie Orozco Moreno
et al.
ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression2023
Dr Kirsty Hodgson
Maggie Orozco Moreno
Dr Emma Scott
Rebecca Garnham
Karen Livermore
et al.
The role of GCNT1 mediated O-glycosylation in aggressive prostate cancer2023
Dr Emma Scott
Dr Kirsty Hodgson
Kat Cheung
Edward Yo
Laura Wilson
et al.
Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth2023
Dr Jennifer Munkley
Aberrant Sialylation in Cancer: Therapeutic Opportunities2022
Adam Duxfield
Dr Jennifer Munkley
Professor Michael Briggs
Dr Ella Dennis
CRELD2 is a novel modulator of calcium release and calcineurin-NFAT signalling during osteoclast differentiation2022
Dr Emma Scott
Rebecca Garnham
Adam Duxfield
Professor David Elliott
Dr Jennifer Munkley
et al.
Pro-Survival Factor EDEM3 Confers Therapy Resistance in Prostate Cancer2022
Kayla Bastian
Dr Emma Scott
Professor David Elliott
Dr Jennifer Munkley
Fut8 alpha-(1,6)-fucosyltransferase in cancer2021
Dr Emma Scott
Professor David Elliott
Dr Jennifer Munkley
Tumour associated glycans: A route to boost immunotherapy?2020
Alice Coomer
Dr Fiona Black
Professor Alastair Greystoke
Dr Jennifer Munkley
Professor David Elliott
et al.
Alternative splicing in lung cancer2019
Dr Jennifer Munkley
SR Gokul Krishnan
Gerald Hysenaj
Dr Emma Scott
Caroline Dalgliesh
et al.
Androgen-regulated transcription of ESRP2 drives alternative splicing patterns in prostate cancer2019
Emma Scott
Dr Jennifer Munkley
Glycans as Biomarkers in Prostate Cancer2019
Rebecca Garnham
Dr Emma Scott
Karen Livermore
Dr Jennifer Munkley
ST6GAL1: A key player in cancer (Review)2019
Dr Jennifer Munkley
Dr Emma Scott
Targeting Aberrant Sialylation to Treat Cancer2019
Dr Jennifer Munkley
The glycosylation landscape of pancreatic cancer2019
Dr Jennifer Munkley
Karen Livermore
Dr Ingrid Ehrmann
Dr Katherine James
Dr Prabhakar Rajan
et al.
Androgen-dependent alternative mRNA isoform expression in prostate cancer cells2018
Dr Jennifer Munkley
Glycosylation is a global target for androgen control in prostate cancer cells2017
Dr Jennifer Munkley
Karen Livermore
Dr Prabhakar Rajan
Professor David Elliott
RNA splicing and splicing regulator changes in prostate cancer pathology2017
Dr Jennifer Munkley
Dr Urszula McClurg
Karen Livermore
Dr Ingrid Ehrmann
Professor Craig Robson
et al.
The cancer-associated cell migration protein TSPAN1 is under control of androgens and its upregulation increases prostate cancer cell migration2017
Karen Livermore
Dr Jennifer Munkley
Professor David Elliott
Androgen receptor in prostate cancer2016
Dr Jennifer Munkley
Karen Livermore
Dr Katherine James
Dr Brian Wilson
Professor Craig Robson
et al.
Glycosylation is an Androgen-Regulated Process Essential for Prostate Cancer Cell Viability2016
Dr Jennifer Munkley
Professor David Elliott
Hallmarks of glycosylation in cancer2016
Dr Irina Neganova
Dr Evgeniya Shmeleva
Dr Jennifer Munkley
Dr Valeria Chichagova
Dr George Anyfantis
et al.
JNK/SAPK signalling is essential for efficient reprogramming of human fibroblasts to induced pluripotent stem cells2016
Dr Jennifer Munkley
Professor David Elliott
Sugars and cell adhesion: the role of ST6GalNAc1 in prostate cancer progression2016
Dr Jennifer Munkley
Professor David Elliott
The role of glycans in the development and progression of prostate cancer2016
Dr Jennifer Munkley
The Role of Sialyl-Tn in Cancer2016
Dr Jennifer Munkley
Professor Craig Robson
Professor Hing Leung
Dr Prabhakar Rajan
Professor David Elliott
et al.
Androgen-regulation of the protein tyrosine phosphatase PTPRR activates ERK1/2 signalling in prostate cancer2015
Dr Brian Wilson
Dr Jennifer Munkley
Metronidazole Toxicity in Cockayne Syndrome: A Case Series2015
Dr Jennifer Munkley
Dr Brian Wilson
Karen Livermore
Dr Vasileios Floros
Professor Craig Robson
et al.
The androgen receptor controls expression of the cancer-associated sTn antigen and cell adhesion through induction of ST6GalNAc1 in prostate cancer2015
Dr Jennifer Munkley
Karen Livermore
Dr Urszula McClurg
Professor Craig Robson
Dr Prabhakar Rajan
et al.
The PI3K regulatory subunit gene PIK3R1 is under direct control of androgens and repressed in prostate cancer cells2015
Dr Veronika Boczonadi
Dr Juliane Mueller
Dr Angela Pyle
Dr Jennifer Munkley
Michele Giunta
et al.
EXOSC8 mutations alter mRNA metabolism and cause hypomyelination with spinal muscular atrophy and cerebellar hypoplasia2014
Dr Jennifer Munkley
Dr Prabhakar Rajan
Caroline Dalgliesh
Robert Jackson
Professor Craig Robson
et al.
A novel androgen-regulated isoform of the TSC2 tumour suppressor gene increases cell proliferation2014